GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » 1-Year ROIIC %

LTR Pharma (ASX:LTP) 1-Year ROIIC % : -761.11% (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. LTR Pharma's 1-Year ROIIC % for the quarter that ended in Jun. 2023 was -761.11%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for LTR Pharma's 1-Year ROIIC % or its related term are showing as below:

ASX:LTP's 1-Year ROIIC % is ranked worse than
89.39% of 1461 companies
in the Biotechnology industry
Industry Median: -4.95 vs ASX:LTP: -761.11

LTR Pharma 1-Year ROIIC % Historical Data

The historical data trend for LTR Pharma's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma 1-Year ROIIC % Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23
1-Year ROIIC %
- 226.36 -761.11

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23
1-Year ROIIC % - 226.36 -761.11

Competitive Comparison of LTR Pharma's 1-Year ROIIC %

For the Biotechnology subindustry, LTR Pharma's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LTR Pharma's 1-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LTR Pharma's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where LTR Pharma's 1-Year ROIIC % falls into.



LTR Pharma 1-Year ROIIC % Calculation

LTR Pharma's 1-Year ROIIC % for the quarter that ended in Jun. 2023 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -1.436 (Jun. 2023) - -1.025 (Jun. 2022) )/( 0.354 (Jun. 2023) - 0.3 (Jun. 2022) )
=-0.411/0.054
=-761.11%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


LTR Pharma  (ASX:LTP) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


LTR Pharma 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of LTR Pharma's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


LTR Pharma (ASX:LTP) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines